Monitoring (medicine)

LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark

Retrieved on: 
Wednesday, August 30, 2023
Cardiology, Software, Health, FDA, Medical Devices, Health Technology, Technology, Other Health, Partnership, PLC, ILBM, LIVN, Perfusion, Hematocrit, Oxygen, CE marking, Food and Drug Administration, LivaNova, CPB, Multimedia, Temperature, Cardiopulmonary bypass, Sale, United Arab Emirates, CLIA, Journal, Acute kidney injury, GDP, Patient, Risk, Stazione Sperimentale per le Industrie delle Essenze e dei Derivati dagli Agrumi, Clinical Laboratory Improvement Amendments, Perfusionist, HLM, Partial pressure, Food, Monitoring (medicine), Medical device, Medical imaging

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM), which provides accurate and continuous measurement of essential blood parameters to perfusionists throughout cardiopulmonary bypass (CPB) procedures.

Key Points: 
  • LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM), which provides accurate and continuous measurement of essential blood parameters to perfusionists throughout cardiopulmonary bypass (CPB) procedures.
  • “Dynamic conditions can rapidly change a patient’s blood parameters during a cardiopulmonary bypass procedure,” said Marco Dolci, LivaNova President, Cardiopulmonary.
  • “The Essenz In-Line Blood Monitor provides continuous monitoring throughout a patient’s procedure.
  • It consists of a next-generation heart-lung machine (HLM), a patient monitor and accurate sensing technology that now includes the ILBM.

The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code

Retrieved on: 
Friday, May 19, 2023
Blood pressure, Telehealth, Muscle soreness, COVID-19, Remote patient monitoring, Canton Fair, Immunity, Organization, System, Thermoregulation, Hospital, Patient, Fair, APP, Health, Monitoring (medicine), Medical device, Medical imaging

As the public becomes more vigilant about their health, medical institutions are also stepping up their game in providing top-notch services and equipment.

Key Points: 
  • As the public becomes more vigilant about their health, medical institutions are also stepping up their game in providing top-notch services and equipment.
  • In the 133rd Canton Fair, over 700 companies showcased their latest offerings of home-use and professional medical equipment, ranging from therapy machines to patient monitors and habitation conditioning machines.
  • "Our mission is to offer health care and physical therapy solutions to individuals worldwide that fundamentally repair the body and enhance immunity."
  • For more information about Canton Fair and to deeply explore the latest innovative technology from the exhibited medical equipment, please register at https://invitation.cantonfair.org.cn/BuyerUser/RegisterUser?MediaType=16 or contact [email protected] .

The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code

Retrieved on: 
Friday, May 19, 2023
Blood pressure, Telehealth, Muscle soreness, COVID-19, Remote patient monitoring, Canton Fair, Immunity, Multimedia, Organization, System, Thermoregulation, Hospital, Patient, Fair, APP, Health, Monitoring (medicine), Medical device, Medical imaging

As the public becomes more vigilant about their health, medical institutions are also stepping up their game in providing top-notch services and equipment.

Key Points: 
  • As the public becomes more vigilant about their health, medical institutions are also stepping up their game in providing top-notch services and equipment.
  • In the 133rd Canton Fair, over 700 companies showcased their latest offerings of home-use and professional medical equipment, ranging from therapy machines to patient monitors and habitation conditioning machines.
  • "Our mission is to offer health care and physical therapy solutions to individuals worldwide that fundamentally repair the body and enhance immunity."
  • For more information about Canton Fair and to deeply explore the latest innovative technology from the exhibited medical equipment, please register at https://invitation.cantonfair.org.cn/BuyerUser/RegisterUser?MediaType=16 or contact [email protected] .

LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures

Retrieved on: 
Thursday, March 9, 2023
Hardware, FDA, Health Technology, Other Health, Technology, Surgery, Mental Health, Medical Devices, Hospitals, Clinical Trials, Cardiology, Biotechnology, Science, Software, Research, Health, PMDA, Perfusion, OR, Hospital, LivaNova, CPB, Medicines and Healthcare products Regulatory Agency, State, Monitoring (medicine), GDP, Sale, HLM, Cardiopulmonary bypass, Partnership, Perfusionist, Patient, Risk, Food, Multimedia, Risk management, PLC, Acute kidney injury, LIVN, Health Canada, Food and Drug Administration, Franciscan Health Indianapolis, Safety, Medical device, Online shopping, Stazione Sperimentale per le Industrie delle Essenze e dei Derivati dagli Agrumi

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM).

Key Points: 
  • LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM).
  • With FDA clearance, LivaNova initiates the commercial launch of Essenz in the U.S.
  • The Essenz HLM and Essenz™ Patient Monitor comprise the Essenz™ Perfusion System, which enables a patient-tailored perfusion approach rooted in data-driven decisions that improve both clinical workflows and quality of patient care during cardiopulmonary bypass (CPB) procedures.
  • Key attributes of the Essenz Perfusion System include:
    The system is built on the proven LivaNova S5™ HLM, which has supported millions of patients for safe CPB procedures.

ivWatch Extends Its Global Reach Signing Three New Distribution Partners

Retrieved on: 
Thursday, August 11, 2022
FDA, Multimedia, Association, Intelligence, Risk, Technology, Business development, Monitoring (medicine), Hospital, LLC, German–Japanese industrial co-operation before World War II, Company, Twitter, Justin Doellman, Safety, Continuity, Profile, Social media, Solution, LinkedIn, Emerging market, Remote patient monitoring, Medical imaging, Medical device, NEWS

NEWPORT NEWS, Va., Aug. 11, 2022 /PRNewswire/ -- Today, ivWatch, LLC, an innovative IV safety company working to eliminate harm caused by infiltration and extravasation events, announced three new strategic distribution partnerships internationally. Bameco in Austria, Warba Medical Supplies in Kuwait, and Mustafa Sultan Science & Industry Co, LLC in Oman have each signed exclusive agreements to promote, sell, and support ivWatch's continuous monitoring products in their markets. ivWatch's novel technologies will complement and bolster their existing portfolios of intravenous products provided to hospitals and other health care facilities.

Key Points: 
  • ivWatch's novel technologies will complement and bolster their existing portfolios of intravenous products provided to hospitals and other health care facilities.
  • Continuous IV site monitoring provides accurate and precise insights to detect infiltrations and extravasations at their earliest stages.
  • ivWatch technology performs with high accuracy, intelligence, and low false alarm rates, which is critical to improving patient outcomes.
  • To learn more, follow us on Twitter @ivWatch , Facebook @ivWatchLLC , LinkedIn @ivWatch or visit www.ivWatch.com .

LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures

Retrieved on: 
Friday, April 8, 2022
Software, Research, Technology, Medical Devices, Hospitals, Surgery, Clinical Trials, Science, Cardiology, Biotechnology, FDA, Practice Management, Health, CPB, LIVN, NASDAQ, Sale, Risk, Monitoring (medicine), Patient, GUI, Head, Hospital, Standard of care, Cardiopulmonary bypass, Food, LivaNova, GDP, Health, PLC, CE marking, Food and Drug Administration, Hope, Perfusion, News, Annual report, Intra, Seamless, Medical device, Medicine

The transformative monitoring system uses a patient-tailored approach to improve clinical efficiency and quality of patient care during cardiopulmonary bypass (CPB) procedures.

Key Points: 
  • The transformative monitoring system uses a patient-tailored approach to improve clinical efficiency and quality of patient care during cardiopulmonary bypass (CPB) procedures.
  • The Essenz Patient Monitor is the result of an intense user-centric design process we have undertaken with perfusionists, said Marco Dolci, President, Cardiopulmonary at LivaNova.
  • Learn more about the Essenz Patient Monitor and the entire Essenz Perfusion System on the LivaNova website.
  • These statements include, but are not limited to, statements regarding the Essenz Perfusion System, the Essenz Patient Monitor and their respective targeted commercial launches.